Cassini Investigators

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.

Cassini Investigators, 2019 .

sirolimus-eluting stent: A post hoc subanalysis of the pooled E- and C-SIRIUS Direct stenting of native de novo coronary artery lesions with the

A. Gershlick, W. Wijns, J. Schofer, 2011 .